Skip to content
HORMONES (Archive)
  • HOME
  • ARCHIVE
    • VOLUME 16 (2017)
    • VOLUME 15 (2016)
    • VOLUME 14 (2015)
    • VOLUME 13 (2014)
    • VOLUME 12 (2013)
    • VOLUME 11 (2012)
    • VOLUME 10 (2011)
    • VOLUME 9 (2010)
    • VOLUME 8 (2009)
    • VOLUME 7 (2008)
    • VOLUME 6 (2007)
      • Issue 1 (January-March)61
      • Issue 2 (April-June)62
    • VOLUME 5 (2006)
      • Issue 1 (January-March)51
      • Issue 2 (April-June)52
    • VOLUME 4 (2005)
      • Issue 1 (January-March)41
      • Issue 2 (April-June)42
    • VOLUME 3 (2004)
    • VOLUME 2 (2003)
    • VOLUME 1 (2002)
      • Issue 1 (January-March)
      • Issue 2 (April-June)12
      • Issue 3 (July-September)13
      • Issue 4 (October- December)14
  • SEARCH
  • CONTACT US

Tag: IGF-II

The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease

Posted on by

Read More

Posted in Issue 3 (July-September)33, Journal Articles, Volume 3 (2004) Tagged -II, -III, IGF binding protein-I, IGF-I, IGF-II, Somatostatin analogue, Thyroid eye disease Leave a comment

Hypoglycaemia secondary to the secretion of pro-insulin like growth factor ii by a metastatic neuroendocrine tumour with sarcomatous differentiation

Posted on by

Read More

Posted in Issue 2 (April-June)22, Journal Articles, Volume 2 (2003) Tagged Hypoglycemia, IGF-II, neuroendocrine tumour Leave a comment
Theme by Out the Box